Kaken Pharmaceutical Co., Ltd.Kaken Pharmaceutical Co., Ltd.Kaken Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪871.63 M‬USD
0.13USD
‪92.96 M‬USD
‪626.84 M‬USD
‪22.31 M‬
Beta (1Y)
0.35
Employees (FY)
‪1.13 K‬
Change (1Y)
−9 −0.79%
Revenue / Employee (1Y)
‪556.69 K‬USD
Net income / Employee (1Y)
‪82.56 K‬USD

About Kaken Pharmaceutical Co., Ltd.


Headquarters
Tokyo
Founded
1948
ISIN
JP3207000005
FIGI
BBG001KLZF42
Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. Its operates through the Pharmaceutical and Real Estate business segments. The Pharmaceutical segment mainly manufactures and sells pharmaceuticals, medical devices and agricultural chemicals. The Real Estate segment rents real estate related to Bunkyo Green Court. The company was founded in March 1917 and is headquartered in Tokyo, Japan.

Check out other big names from the same industry as KKPCF.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
1306
Next Funds TOPIX Exchange Traded Fund
Weight
0.01%
Market value
‪21.35 M‬
USD
1308
Nikko Exchange Traded Index Fund TOPIX
Weight
0.01%
Market value
‪10.07 M‬
USD
1305
iFreeETF TOPIX
Weight
0.01%
Market value
‪9.38 M‬
USD
1494
One ETF High Dividend Japan Equity
Weight
1.51%
Market value
‪7.64 M‬
USD
1348
MAXIS TOPIX ETF
Weight
0.01%
Market value
‪3.02 M‬
USD
1475
iShares Core TOPIX ETF
Weight
0.01%
Market value
‪1.95 M‬
USD
SCHC
Schwab International Small-Cap Equity ETF
Weight
0.03%
Market value
‪1.61 M‬
USD
0A3F
iShares Core MSCI Japan IMI UCITS ETF
Weight
0.01%
Market value
‪1.04 M‬
USD
IJPA
iShares Core MSCI Japan IMI UCITS ETF
Weight
0.01%
Market value
‪1.04 M‬
USD
SJPE
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged Accum
Weight
0.01%
Market value
‪1.04 M‬
USD
SJPD
iShares Core MSCI Japan IMI UCITS ETF
Weight
0.01%
Market value
‪1.04 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of KKPCF is 24.00 USD — it has decreased by −14.57% in the past 24 hours. Watch Kaken Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Kaken Pharmaceutical Co., Ltd. stocks are traded under the ticker KKPCF.
We've gathered analysts' opinions on Kaken Pharmaceutical Co., Ltd. future price: according to them, KKPCF price has a max estimate of 34.58 USD and a min estimate of 23.05 USD. Watch KKPCF chart and read a more detailed Kaken Pharmaceutical Co., Ltd. stock forecast: see what analysts think of Kaken Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
KKPCF reached its all-time high on Apr 29, 2022 with the price of 39.84 USD, and its all-time low was 22.30 USD and was reached on Apr 16, 2024. View more price dynamics on KKPCF chart.
See other stocks reaching their highest and lowest prices.
KKPCF stock is 17.05% volatile and has beta coefficient of 0.35. Track Kaken Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Kaken Pharmaceutical Co., Ltd. there?
Today Kaken Pharmaceutical Co., Ltd. has the market capitalization of ‪916.39 M‬, it has increased by 0.04% over the last week.
Yes, you can track Kaken Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Kaken Pharmaceutical Co., Ltd. is going to release the next earnings report on Feb 11, 2026. Keep track of upcoming events with our Earnings Calendar.
KKPCF net income for the last quarter is ‪4.87 M‬ USD, while the quarter before that showed ‪1.88 M‬ USD of net income which accounts for 159.19% change. Track more Kaken Pharmaceutical Co., Ltd. financial stats to get the full picture.
Kaken Pharmaceutical Co., Ltd. dividend yield was 4.24% in 2024, and payout ratio reached 52.00%. The year before the numbers were 4.34% and 70.54% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 8, 2025, the company has ‪1.13 K‬ employees. See our rating of the largest employees — is Kaken Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kaken Pharmaceutical Co., Ltd. EBITDA is ‪29.60 M‬ USD, and current EBITDA margin is 25.09%. See more stats in Kaken Pharmaceutical Co., Ltd. financial statements.
Like other stocks, KKPCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kaken Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kaken Pharmaceutical Co., Ltd. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kaken Pharmaceutical Co., Ltd. stock shows the sell signal. See more of Kaken Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.